Built in the heart of the Quinze-Vingts National Eye Hospital Paris, France, the Vision Institute is one of the most important research centers in Europe on eye diseases.

During the past decade, Institut de la vision conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut de la vision" #1 collaborator was "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institut de la vision" are "Pigmentary Retinopathy" (1 trials) and "Stargardt Disease" (1 trials). Many other conditions were trialed in "Institut de la vision" in a lesser frequency.

Most popular intervention types in "Institut de la vision" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Eye tracker" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut de la vision" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institut de la vision". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Institut de la vision, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut de la vision, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".